Akin Gump Advises Kennedy Lewis in Proposed Acquisition
Contact:
(New York) – An Akin Gump team is advising funds affiliated with Kennedy Lewis Investment Management LLC in its proposed acquisition of Rapid Micro Biosystems, Inc. (RPID).
Kennedy Lewis proposed in a letter to RPID’s board that one or more of Kennedy Lewis’ funds would acquire 100% of RPID for $5.00 per share in cash, representing a substantial premium of approximately 57% to the closing share price of $3.18 on June 29, 2022.
Kennedy Lewis is an opportunistic credit manager founded in 2017 with approximately $10 billion under management across private funds and collateralized loan obligations. As of June 30, funds affiliated with Kennedy Lewis own approximately 14.14% of the issued and outstanding Class A common stock of RPID.
The Akin Gump team advising Kennedy Lewis is being led by integrated special situations group leader Daniel Fisher and corporate practice co-head Zachary Wittenberg.
Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
# # #
People Mentioned in This News
